Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2002
05/16/2002US20020058029 Anti-CD40L, anti-B7.1 (CD80), anti-B7.2(CD86), CD40 antibody or anti-CD4 antibody; both may be administered separately or in combination, and in any order.
05/16/2002US20020056206 Spray drying process and compositions of fenofibrate
05/16/2002CA2428669A1 High-density lipoprotein-cholesterol level elevating agent
05/16/2002CA2428492A1 Method for screening agents by modulating the expression of sparc
05/16/2002CA2428204A1 Lipid peroxide-lowering compositions
05/16/2002CA2428176A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2
05/16/2002CA2428159A1 Delayed-release pharmaceutical formulations containing proinsulin c-peptide
05/16/2002CA2427757A1 Therapeutic uses for ip3 receptor-mediated calcium channel modulators
05/16/2002CA2427350A1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands
05/16/2002CA2426730A1 Calcilytic compounds
05/16/2002CA2426037A1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
05/16/2002CA2421594A1 3-substituted oxindole beta 3 agonists
05/16/2002CA2421154A1 Peroxisome proliferator activated receptor alpha agonists
05/15/2002EP1205489A1 Polypeptide and nucleic acids encoding the same
05/15/2002EP1205478A1 p38MAP KINASE INHIBITORS
05/15/2002EP1205477A1 Mutual prodrug of amlodipine and atorvastatin
05/15/2002EP1205191A1 Targeted modification of intracellular compounds
05/15/2002EP1204748A2 New g-protein coupled receptor and dna sequences thereof
05/15/2002EP1204674A2 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders
05/15/2002EP1204665A2 Chemokine receptor antagonists and methods of use therefor
05/15/2002EP1204660A1 Serotonergic benzothiophenes
05/15/2002EP1204659A2 Serotonergic benzofurans
05/15/2002EP1204658A1 Benzofurylpiperazine serotonin agonists
05/15/2002EP1204656A2 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene hydrochloride
05/15/2002EP1204655A2 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride
05/15/2002EP1204654A1 Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists
05/15/2002EP1204652A1 Novel succinate derivative compounds useful as cysteine protease inhibitors
05/15/2002EP1204646A1 1,4,5,6 -tetrahydropyrimidine derivative as a vitronectin inhibitor
05/15/2002EP1204626A1 Ether compounds, compositions, and uses thereof
05/15/2002EP1204429A2 Sustained release formulation of a peptide
05/15/2002EP1204414A2 Use of morphinan derivates as medicines
05/15/2002EP1167360A9 Human chymase inhibitors
05/15/2002EP1082028B1 Matthiola seed oil, mixtures containing it and use thereof
05/15/2002EP1049694B1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines
05/15/2002EP0751775B1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide derivatives
05/15/2002EP0750509B1 USE OF IL-12 AND IL-12 ANTAGONISTS for the manufacture of a pharmaceutical composition for THE TREATMENT OF AUTOIMMUNE DISEASES
05/15/2002EP0748314B1 Tetrasubstituted imidazole derivatives, method for preparing the same, use thereof as drugs, and pharmaceutical compositions containing the same
05/15/2002CN1349527A Substituted benzolactam compounds
05/15/2002CN1349525A Di-aryl acid derivatives as PPAR receptor ligands
05/15/2002CN1349519A Glucokinase activators
05/15/2002CN1349510A Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors
05/15/2002CN1349509A Heterocyclic urea and related compounds useful as anti-inflammatory agents
05/15/2002CN1349502A Method for the prepn. of tricyclic amino alcohol derivatives through azides
05/15/2002CN1349496A Caspase inhibitors and the use thereof
05/15/2002CN1349485A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators
05/15/2002CN1349404A Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis treatment of obesity
05/15/2002CN1348815A Medicine for preventing and treating coronary heart disease and angina pectoris and its prepn and other use
05/15/2002CN1348786A Antilipemic slimming tea prepn
05/15/2002CN1348785A Medicine 'Xuewang' for treating anemia
05/15/2002CN1348778A Chinese medicine prepn for treating AIDS, cancer, hepatitis, diabetes and angiopathy
05/15/2002CN1348768A 活性山羊血粉胶囊 Activity goat blood meal capsule
05/15/2002CN1348763A Medicine composite for preventing or treaitng diseases relating to IL-12 over growth
05/15/2002CN1348762A Application of kusheng (sophora Flavescences) flavone in preparing hypoglycemic
05/15/2002CN1348717A Diatotherapeutic flour for treating diabetes and its production process
05/15/2002CN1084747C Azolobenzazepine derivs, as neurological active agents
05/15/2002CN1084744C N-substituted azaheterocyclic compounds
05/15/2002CN1084741C Novel benzothiepines having activities as inhibitors of ileal bile acid transport and taurocholate uptake
05/15/2002CN1084736C Substituted bheterocyclic carboxamide esters, their prepn. and their use as pharmaceuticals
05/14/2002US6388088 Antidiabetic agents
05/14/2002US6388071 Alkynyl phenyl heteroaromatic glucokinase activators
05/14/2002US6388053 Mixing glucagon-like peptide-1 with a divalent metal cation, then incubating to form a complex; antidiabetic agents
05/14/2002US6388047 Hydrophobic, hydrophilic macromolecules
05/14/2002US6387944 Benzo(b)thiepine-1,1-dioxide derivatives, a method for the production thereof, medicaments containing these compounds, and their use
05/14/2002US6387941 Antiserotonine agents
05/14/2002US6387937 Indole derivatives
05/14/2002US6387935 Polycyclic dihydrothiazoles having substituted alkyl radicals in the two-position, process for their preparation, and their use as pharmaceuticals
05/14/2002US6387934 2-Cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives
05/14/2002US6387932 Somatostatin agonists
05/14/2002US6387929 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
05/14/2002US6387919 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
05/14/2002US6387899 Antiserotonine agents; antidepressants
05/14/2002US6387894 Use of CRF antagonists and renin-angiotensin system inhibitors
05/14/2002US6387892 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
05/14/2002US6387883 Method for the prevention and treatment of cachexia and anorexia
05/14/2002US6387663 Fusion protein of collagen binding domain and angiogenesis modulating domain; treatment of cardiovascular disorders; antiischemic agents
05/14/2002CA2255665C Creatine pyruvates and method for their production
05/14/2002CA2251991C Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
05/14/2002CA2089742C Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus
05/10/2002WO2002036771A2 Imaging, diagnosis and treatment of disease
05/10/2002WO2002036765A1 Novel protein and dna thereof
05/10/2002WO2002036741A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
05/10/2002WO2002036602A1 Novel pyrazole derivatives and diabetes remedies containing the same
05/10/2002WO2002036597A1 Tricyclic derivatives of indole with antiangiogenic activity
05/10/2002WO2002036584A1 Cholesterol lowering benzo`b! thiophenes and benzo`d! isothiazoles
05/10/2002WO2002036573A2 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
05/10/2002WO2002036563A1 Crystalline forms of fluvastatin sodium
05/10/2002WO2002036543A1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride
05/10/2002WO2002036151A2 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
05/10/2002WO2002036134A1 Pharmaceutical or dietary composition containing a vegetable oil, in particular olive oil, and sitosterol
05/10/2002WO2002036116A2 Tripeptidyl peptidase inhibitors
05/10/2002WO2002036115A1 Sulphonamides for the treatment of central nervous system diseases
05/10/2002WO2002036111A1 New use of 2-(4-isobutylphenyl)propionic acid
05/10/2002WO2002036109A2 Use of pyridoxamine for the treatment and inhibition of obesity-related complications
05/10/2002WO2002036100A1 Controlled release metformin compositions
05/10/2002WO2002036093A2 Anti-adiposis composition based on garlic bulb extracts
05/10/2002WO2002036073A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same
05/10/2002WO2002035942A1 Food grade transglutaminase inhibitor and uses thereof
05/10/2002WO2002015927A8 High mannose proteins and methods of making high mannose proteins
05/10/2002WO2002012238A3 2-(4-PYRIDYL)AMINO-6-DIALKOXYPHENYL-PYRIDO[2,3-d]PYRIMIDIN-7-ONES
05/10/2002WO2002008200A3 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists